February 2, 2026
Source: drugdu
34
LimX Dynamics announced the completion of a $200 million Series B financing round, with Cornerstone Capital as a participant.
With full-stack technology, we grasp the pivotal capabilities that drive embodied intelligence toward real-world deployment.
As we step into 2026, with the strong support of our existing and new shareholders as well as partners, LimX Dynamics will scale up its investment in R&D and market expansion. Grounded in three core competencies: proprietary hardware design and manufacturing, cerebellum foundation models, and the embodied Agentic OS, LimX Dynamics focuses on breakthroughs in the core technology of fusing the “brain and cerebellum” for embodied intelligence. The company advances original innovation in general-purpose humanoid robots and modular base robots, and will further expand its presence in both the Chinese and global markets through product engineering and the development of a supply chain ecosystem.
Over the past two months, LimX Dynamics has successively launched two pivotal innovative products and technologies: the multi-modal embodied robot TRON 2 and the embodied agent operating system LimX COSA, both of which have garnered extensive global attention and recognition.
TRON 2: A General-Purpose Embodied Intelligence Base for Technical and Scenario Validation
Featuring an original modular design, TRON 2 supports the flexible combination of multiple configurations, integrating both mobility and manipulation capabilities in one platform. This empowers developers and industrial users to rapidly build robot configurations tailored to diverse application scenarios, eliminating the need for repeated hardware customization for single tasks. TRON 2 serves as a reusable, scalable, and continuously evolvable general-purpose base for embodied intelligence.
LimX COSA: The Embodied Agentic OS That Enables Robots to “Think While Acting”
LimX COSA is an independently developed, physically native embodied Agentic OS created by LimX Dynamics. It deeply integrates high-level cognitive and decision-making capabilities with full-body motion control. Powered by COSA, the humanoid robot Oli no longer relies on fixed scripts; instead, it can comprehend tasks, perceive the environment, plan actions, and continuously adjust decisions during execution to adapt to dynamic environments and evolving tasks. LimX COSA conducts unified scheduling of models, skills, and robot embodiments, empowering embodied intelligent robots to autonomously complete complex tasks in real-world scenarios.
Amid the pivotal window of opportunity for the global development of the embodied intelligence industry, LimX Dynamics remains committed to original innovation, taking product strength and user demand as its fundamental principles. The company will work together with global partners to advance the validation and real-world deployment of embodied intelligence robots, enabling technological innovation to serve humanity.
About LimX Dynamics
LimX Dynamics is an AI-driven humanoid robotics company focused on developing full-size, general-purpose humanoid robots, with a portfolio of derivative innovative products including bipedal robots.
LimX Dynamics is committed to disruptive innovation in embodied intelligence, unlocking the generalization capabilities of AGI in the physical world. Centered on three core embodied intelligence technologies—proprietary hardware design and manufacturing, brain-cerebellum fusion technology, and the embodied Agentic OS—the company drives technological innovation, development, and widespread adoption of embodied intelligence across research, manufacturing, commercial, and household sectors.
Founded in 2022, LimX Dynamics maintains its global headquarters in Shenzhen, China. For more information about us, please follow our official WeChat Official Account “LimX Dynamics” or visit our website at: www.limxdynamics.com.
your submission has already been received.
OK
Please enter a valid Email address!
Submit
The most relevant industry news & insight will be sent to you every two weeks.